Company / R&D per Share
Aligos Therapeutics, Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.87
FY2025
5-year range
$0.87 / $23.39
FY2021-FY2025
Trend
-96.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 6 years, ranging from $0.87 in FY2025 to $23.39 in FY2024.
Based on SEC 10-K filings.
0.87 in FY2025 with a 5-year CAGR of -40.0%.
Declined from $1.98 to $0.87 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -29.1%
- 5-Year CAGR
- -40.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 96.3% year-over-year.
- Peak r&d per share was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | -96.3% |
| FY2024 | $23.39 | +1080.2% |
| FY2023 | $1.98 | -18.8% |
| FY2022 | $2.44 | +16.4% |
| FY2021 | $2.10 | -81.3% |
| FY2020 | $11.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026